Tepotinib, also known as EMD 1214063 and MSC2156119, is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor EMD 1214063 selectively binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase.
Related Products:
Capmatinib; MK-8033; Merestinib; SGX-523; MDK-0264; NPS-1034; WYE-125132; PHA-665752; SCR-1481B1; SU11606